Manni A, Buckwalter E, Etindi R, Kunselman S, Rossini A, Mauger D, Dabbs D, Demers L
Department of Medicine, Pennsylvania State University College of Medicine, Hershey 17033, USA.
Cell Growth Differ. 1996 Sep;7(9):1187-98.
To address the isoenzyme-specific involvement of protein kinase C (PKC) in breast cancer biology, hormone-responsive MCF-7 breast cancer cells were infected with either PKC-alpha or -beta 1 cDNAs subcloned in the retroviral expression vector pMV7. Several stable clones of PKC-overexpressing cells were generated. Western analysis revealed cross-regulation between the alpha and beta isoforms, because induction of overexpression of one up-regulated the other. Overexpression of the alpha and beta isoenzymes, on the other hand, did not affect the already high endogenous expression of the novel delta, epsilon, eta, and zeta isoforms. Compared with control clones, PKC-alpha- and -beta-overexpressing MCF-7 cells exhibited more drastic morphological changes in response to phorbol 12-myristate 13-acetate administration characterized by cellular flattening and vacuolization. More importantly, induction of PKC-alpha and -beta overexpression induced a less aggressive biological behavior, which was characterized by reduced in vitro invasiveness and markedly diminished tumor formation and growth in nude mice. These in vivo findings can probably best be explained by the dramatic down-regulation of estrogen receptor levels observed in tumors derived from PKC-alpha-infected MCF-7 cells. Our data clearly show that it is possible to induce a less aggressive breast cancer phenotype by altering PKC isoenzyme expression.
为了研究蛋白激酶C(PKC)的同工酶在乳腺癌生物学中的特异性作用,将PKC-α或-β1的互补DNA(cDNA)亚克隆到逆转录病毒表达载体pMV7中,感染激素反应性MCF-7乳腺癌细胞。生成了几个PKC过表达细胞的稳定克隆。蛋白质印迹分析显示α和β同工型之间存在交叉调节,因为一种同工型的过表达诱导会使另一种同工型上调。另一方面,α和β同工酶的过表达并不影响新的δ、ε、η和ζ同工型已经很高的内源性表达。与对照克隆相比,过表达PKC-α和-β的MCF-7细胞在给予佛波醇12-肉豆蔻酸酯13-乙酸酯后表现出更剧烈的形态变化,其特征为细胞扁平及空泡化。更重要的是,PKC-α和-β过表达的诱导导致侵袭性较低的生物学行为,其特征为体外侵袭性降低,并且在裸鼠体内肿瘤形成及生长明显减少。在源自PKC-α感染的MCF-7细胞的肿瘤中观察到雌激素受体水平显著下调,这可能是对这些体内研究结果的最佳解释。我们的数据清楚地表明,通过改变PKC同工酶的表达有可能诱导出侵袭性较低的乳腺癌表型。